Yes of course Col, I would have to agree the real aim is to provide a solution to the abuse aspect from a company prospective, but like I said, I have a personal reason why I think that people who are Opioid Naive are also considered in this in some way, do you have a problem with that?
Ann: FDA meeting provides guidance for TPM/Oxymorphone patch, page-14
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
